phase ii trial of pembro & epacadostat in patients with recurrent clear cell carcinoma of the ovary
Published 1 year ago • 80 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
2:10
combined pd1 and ido1 inhibiton in patients with clear cell carcinoma of the ovary
-
0:48
phase i/ii trial of adapt-001, an oncolytic virus, and a checkpoint inhibitor in solid tumors
-
2:50
aurelia: phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer
-
0:54
surpass: adp-a2m4cd8 t-cell receptor t-cell therapy and pembrolizumab in uc
-
2:00
exploring the combination of epacadostat and pembrolizumab in urothelial carcinoma
-
6:13
immunotherapy promise for gynaecologic extra-renal clear cell carcinomas
-
6:14
standard of care and progress with parp inhibitors for ovarian cancer
-
1:06
improving immunotherapy outcomes in ovarian cancer
-
2:55
results of engot-ov16/nova phase iii trial of niraparib in platinum-sensitive ovarian cancer
-
2:58
standard of care updates in ovarian cancer: parp inhibitors
-
1:50
dr. hamid on epacadostat plus pembrolizumab in advanced melanoma
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
1:41:03
ovarian cancer symposium 2021: session 2 immunotherapy and targeted therapy
-
2:39
nova phase iii trial of niraparib in platinum-sensitive ovarian cancer patients
-
0:58
dr. wright on pfs as an endpoint in ovarian cancer trials
-
1:26
phase i trial of copanlisib nivolumab in patients with richter’s transformation or transformed fl
-
2:47
aurelia: phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer
-
1:12
where is ovarian cancer treatment headed?